Endocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1

Journal of Investigative Dermatology

Volumn 131, Issue 5, 2011, Pages 1095-1104

  Tóth, Balázs I ^a   Dobrosi, Nóra ^a   Dajnoki, Angéla ^a   Czifra, Gabriella ^a   Oláh, Attila ^a   Szöllsi, Attila G ^a   Juhász, István ^a   Sugawara, Koji ^b   Paus, Ralf ^b,c   Bíró, Tamás ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF LÜBECK   (Germany)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ANANDAMIDE; CALCIUM ION; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CAPSAZEPINE; ENDOCANNABINOID; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; METABOTROPIC RECEPTOR; VANILLOID RECEPTOR 1;

APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; COMPETITIVE INHIBITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EPIDERMIS CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; KERATINOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN TARGETING; PSORIASIS; SIGNAL TRANSDUCTION; SKIN TUMOR; WESTERN BLOTTING;

EID: 79954952532     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.421     Document Type: Article

References (44)

1. Berdyshev EV, Schmid PC, Dong Z et al. (2000) Stress-induced generation of N-acylethanolamines in mouse epidermal JB6 P+ cells. Biochem J 346:369-74 (Pubitemid 30148122)
2. B́iró T, Tóth IB, Haskó G et al. (2009) The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities. Trends Pharmacol Sci 30:411-20
3. Blazquez C, Carracedo A, Barrado L et al. (2006) Cannabinoid receptors as novel targets for the treatment of melanoma. FASEB J 20:2633-5
4. Bodó E, Bíró T, Telek A et al. (2005) A "hot" new twist to hair biology\involvement of vanilloid receptor-1 (VR1/TRPV1) signaling in human hair growth control. Am J Pathol 166:985-98 (Pubitemid 40524424)
5. Calignano A, La Rana G, Giuffrida A et al. (1998) Control of pain initiation by endogenous cannabinoids. Nature 394:277-81 (Pubitemid 28335039)
6. Casanova ML, Blazquez C, Martinez-Palacio J et al. (2003) Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J Clin Invest 111:43-50 (Pubitemid 36134847)
7. Di Marzo V (2008) Targeting the endocannabinoid system: to enhance or reduce? Nat Rev Drug Discov 7:438-55 (Pubitemid 351649182)
8. Di Marzo V, Bisogno T, De Petrocellis L (2001) Anandamide: some like it hot. Trends Pharmacol Sci 22:346-9 (Pubitemid 32592472)
9. Di Marzo V, Bisogno T, Melck D et al. (1998) Interactions between synthetic vanilloids and the endogenous cannabinoid system. FEBS Lett 436: 449-54 (Pubitemid 28482980)
10. Dobrosi N, Tóth IB, Nagy G et al. (2008) Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling. FASEBJ 22:3685-95
11. Fioravanti B, De Felice M, Stucky CL et al. (2008) Constitutive activity at the cannabinoid CB1 receptor is required for behavioral response to noxious chemical stimulation of TRPV1: antinociceptive actions of CB1 inverse agonists. J Neurosci 28:11593-602
12. Foitzik K, Lindner G, Müller-Röver S et al. (2000) Control of murine hair follic le regression (catagen) by TGF-beta1 in vivo. FASEB J 14: 752-60 (Pubitemid 30198573)
13. Green DR, Reed JC (1998) Mitochondria and apoptosis. Science 281: 1309-12 (Pubitemid 28406816)
14. Gönczi M, Telek A, Czifra G et al. (2008) Altered calcium handling following the recombinant overexpression of protein kinase C isoforms in HaCaT cells. Exp Dermatol 17:584-91 (Pubitemid 351803081)
15. Hermann H, De Petrocellis L, Bisogno T et al. (2003) Dual effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated response. Cell Mol Life Sci 60:607-16 (Pubitemid 36459539)
16. Howlett AC (2005) Cannabinoid receptor signaling. Handb Exp Pharmacol 168:53-79
17. Howlett AC, Barth F, Bonner TI et al. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharma-col Rev 54:161-202 (Pubitemid 34575709)
18. Ibrahim MM, Porreca F, Lai J et al. (2005) CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc Natl Acad Sci USA 102:3093-8 (Pubitemid 40299921)
19. Karsak M, Gaffal E, Date R et al. (2007) Attenuation of allergic contact dermatitis through the endocannabinoid system. Science 316:1494-7 (Pubitemid 46906619)
20. Kiss B, Bíró T, Czifra G et al. (2008) Investigation of micronized titanium-dioxide penetration in human skin xenografts and its effect on cellular functions of human skin-derived cells. Exp Dermatol 17:659-67 (Pubitemid 352044358)
21. Kupczyk P, Reich A, Szepietowski JC (2009) Cannabinoid system in the skin-a possible target for future therapies in dermatology. Exp Dermatol 18:669-79
22. Lazar J, Braun DC, Toth A et al. (2006) Kinetics of penetration influence the apparent potency of vanilloids on TRPV1. Mol Pharmacol 69:1166-73
23. Lindner G, Menrad A, Gharadi E et al. (2000) Involvement of hepatocyte growth factor/scatter factor and met receptor signaling in hair follicle morphogenesis and cycling. FASEB J 14:319-32 (Pubitemid 30086069)
24. Lu Z, Hasse S, Bodó E et al. (2007) Towards the development of a simplified long-term organ culture method for human scalp skin and its appendages under serum-free conditions. Exp Dermatol 16:37-44 (Pubitemid 44890349)
25. Maccarrone M, Di Rienzo M, Battista N et al. (2003) The endocannabinoid system in human keratinocytes. Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase. J Biol Chem 278:33896-903 (Pubitemid 37553223)
26. Mackie K (2006) Cannabinoid receptors as therapeutic targets. Annu Rev Pharmacol Toxicol 46:101-22
27. Mechoulam R, Fride E, Di Marzo V (1998) Endocannabinoids. Eur J Pharmacol 359:1-18 (Pubitemid 28515716)
28. Oka S, Wakui J, Ikeda S et al. (2006) Involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in oxazolone-induced contact dermatitis in mice. J Immunol 177:8796-805 (Pubitemid 44893846)
29. Pacher P, Batkai S, Kunos G (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58:389-462 (Pubitemid 44394908)
30. Paradisi A, Pasquariello N, Barcaroli D et al. (2008) Anandamide regulates keratinocyte differentiation by inducing DNA methylation in a CB1 receptor dependent manner. J Biol Chem 283:6005-12
31. Pertwee RG (2005) Pharmacological actions of cannabinoids. Handb Exp Pharmacol 168:1-51
32. Petrosino S, Cristino L, Karsak M et al. (2010) Protective role of palmitoyl-ethanolamide in contact allergic dermatitis. Allergy 65:698-711
33. Slominski A, Wortsman J (2000) Neuroendocrinology of the skin. Endocr Rev 21:457-87
34. Slominski A, Wortsman J, Paus R et al. (2008) Skin as an endocrine organ: implications for its function. Drug Discov Today Dis Mech 5: 137-44
35. Southall MD, Li T, Gharibova LS et al. (2003) Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes. J Pharmacol Exp Ther 304:217-22 (Pubitemid 36008931)
36. Stander S, Schmelz M, Metze D et al. (2005) Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin. J Dermatol Sci 38:177-88 (Pubitemid 40779571)
37. Susin SA, Zamzami N, Kroemer G (1998) Mitochondria as regulators of apoptosis: doubt no more. Biochem Biophys Acta 1366:151-65 (Pubitemid 28467029)
38. Szegedi A, Páyer E, Czifra G et al. (2009) Protein kinase C isoenzymes differentially regulate the differentiation-dependent expression of adhe-sion molecules in human epidermal HaCaT keratinocytes. Exp Dermatol 18:122-9
39. Telek A, B́iró T, Bodó E et al. (2007) Inhibition of human hair follicle growth by endo-and exocannabinoids. FASEB J 21:3534-41 (Pubitemid 350075143)
40. Tiede S, Kloepper JE, Ernst N et al. (2009) Nestin in human skin: exclusive expression in intramesenchymal skin compartments and regulation by leptin. J Invest Dermatol 129:2711-20
41. Tóth IB, Géczy T, Griger Z et al. (2009) Transient receptor potential vanilloid-1 signaling as a regulator of human sebocyte biology. J Invest Dermatol 129:329-39
42. Ursu D, Knopp K, Beattie RE et al. (2010) Pungency of TRPV1 agonists is directly correlated with kinetics of receptor activation and lipophilicity. Eur J Pharmacol 641:114-22
43. Wilkinson JD, Williamson EM (2007) Cannabinoids inhibit human keratino-cyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis. J Dermatol Sci 45:87-92 (Pubitemid 46108487)
44. Zygmunt PM, Petersson J, Andersson DA et al. (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400:452-7 (Pubitemid 29361798)